We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Weekly
    • FDAnews
  • Device News
    • Trending
    • Commercial Operations
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Weekly
    • FDAnews
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • FDAnews Editorial Board
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CardioWise’s Cardiac CT Image Analysis Software Cleared by FDA

CardioWise’s Cardiac CT Image Analysis Software Cleared by FDA

ClearanceStamp_Blue.gif
January 8, 2021

CardioWise has been granted 510(k) marketing clearance for SQuEEZ (Stretch Quantifier for Endocardial Engraved Zones), the company’s imaging analysis software for cardiac computed tomography (CT) studies.

The software, which is designed to help cardiologists and radiologists evaluate heart function in patients with symptoms of heart disease, color codes and highlights motions of the heart wall and it can help to assess the heart’s ability to pump blood through the left ventricle.

Cardiac CT combined with SQuEEZ analysis software “can provide clinicians with a normalized measurement to determine … [if] contractile function [is] normal or not normal,” the company said.

View today's stories

Devices Submissions and Approvals

Upcoming Events

  • 13Jun

    Winners Only: 3 Steps to Compete in Digital Quality

  • 14Jun

    Pharmaceutical Quality Risk Management and ICH Q9(R1): Navigating the Global Intersection of Principle and Regulation

  • 20Jun

    What’s CSA? And how can it streamline your GxP System Verification?

  • 22Jun

    Transforming Life Sciences Training: Top Trends Shaping Enterprise Learning Strategies

  • 12Jul

    FDA’s New Sterilization Pilot on Risk-Based Cleaning and Disinfectant Programs: Best Practices for Quality, Regulatory and Compliance Professionals

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • FDA Launches Real-World Evidence Program, Part of PDUFA VII Commitments

  • Prepare for Potential Hurricane Disruptions, FDA Tells Devicemakers

  • Promosome Sues Moderna, Pfizer Over COVID-19 Patent Infringement

  • FDA Gives Warning Letter to iRhythm for Mislabeled Device, Unreported Deaths

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing